Stock Comparison

BEAM vs REGN

Beam Therapeutics Inc and Regeneron Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.

BEAM

Beam Therapeutics Inc

Healthcare

REGN

Regeneron Pharmaceuticals Inc

Healthcare

Valuation

Market Cap

$3.58B

$66.35B

P/E (TTM)

—

15.5

Forward P/E

—

14.1

Price/Sales

21.8

4.5

Price/Book

3.1

2.1

EV/EBITDA

-7.0

10.5

Dividend Yield

—

0.58%

Profitability

Net Margin

-40.20%

29.60%

Operating Margin

-337.80%

20.70%

Return on Equity

-5.77%

14.50%

Return on Assets

-15.80%

6.13%

Growth (YoY)

Revenue Growth

324.90%

19.00%

Earnings Growth

0.00%

-7.20%

Price & Risk

Beta

2.2

0.2

52-Week High

$36.88

$818.90

52-Week Low

$15.60

$516.07

Analyst Target

$51.07

$833.31

Compare BEAM and REGN your own way

Try mrmarket.ai free

Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.